ALB and cirrhosis of liver: The increase of albumin level after OBV/PTV/r ± DSV ± RBV therapy was documented in non-cirrhotics and compensated cirrhotics in the TOPAZ-I and TOPAZ-II trials after 2 and 3 years of FU, and the improvement was more pronounced in patients with liver cirrhosis, which was earlier noticed after 2 years’ follow-up of patients included in our study [15,19].